KR20090099374A - Fucoidan-enriched extract of brown-seaweed and its manufacturing method - Google Patents
Fucoidan-enriched extract of brown-seaweed and its manufacturing method Download PDFInfo
- Publication number
- KR20090099374A KR20090099374A KR1020080024574A KR20080024574A KR20090099374A KR 20090099374 A KR20090099374 A KR 20090099374A KR 1020080024574 A KR1020080024574 A KR 1020080024574A KR 20080024574 A KR20080024574 A KR 20080024574A KR 20090099374 A KR20090099374 A KR 20090099374A
- Authority
- KR
- South Korea
- Prior art keywords
- seaweed
- extract
- fucoidan
- undaria pinnatifida
- minutes
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 56
- 229920000855 Fucoidan Polymers 0.000 title claims abstract description 54
- 241000199919 Phaeophyceae Species 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 4
- 241001474374 Blennius Species 0.000 claims description 86
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000002787 reinforcement Effects 0.000 claims 1
- 241001261506 Undaria pinnatifida Species 0.000 abstract description 14
- 235000013376 functional food Nutrition 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 3
- 229940006284 undaria pinnatifida extract Drugs 0.000 abstract 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 12
- 239000011707 mineral Substances 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 229920000615 alginic acid Polymers 0.000 description 8
- 235000010443 alginic acid Nutrition 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 239000000783 alginic acid Substances 0.000 description 7
- 229960001126 alginic acid Drugs 0.000 description 7
- 150000004781 alginic acids Chemical class 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 101100291369 Mus musculus Mip gene Proteins 0.000 description 2
- 101150116466 PALM gene Proteins 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000208308 Coriandrum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- OCVXZQOKBHXGRU-UHFFFAOYSA-N iodine(1+) Chemical compound [I+] OCVXZQOKBHXGRU-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000009861 stroke prevention Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric
Abstract
Description
본 발명은 미역추출물에 미역포자엽에서 추출한 후코이단을 보강한 고기능성 임산부 몸조리용 식품과 건강식품 및 그 제조방법에 관한 것이다. 더 상세하게는 미네랄과 다당들을 함유하고 있는 미역의 추출물에 미역포자엽 등에서 추출한 생리활성물질인 후코이단을 첨가하여 미역추출물에 후코이단을 보강한 더욱 완전한 건강식품 및 그 제조방법에 관한 것이다.The present invention relates to a high-functional pregnant women's food and health food supplemented with fucoidan extracted from Wakame spores in seaweed extract and health food and a manufacturing method thereof. More specifically, the present invention relates to a more complete health food supplemented with fucoidan in seaweed extract by adding fucoidan, a bioactive substance extracted from wakame spores, etc. to the extract of wakame seaweed containing minerals and polysaccharides, and a method of manufacturing the same.
전통적으로 미역은 산후조리를 위한 식품으로 활용되어 왔다. 산모에 있어서 미역은 수유를 많게 하고 산후의 늘어난 자궁을 수축시키고, 상처를 아물게 하여 산후 회복을 돕는다. 기본적으로 미역은 피를 맑게 하고, 기(氣)를 회복시키며, 신진대사를 활발하게 하여 거친 피부를 좋게 하고 변비를 개선하는 등의 기능을 가지고 있어 필수산후조리식품으로 자리 잡아 왔다.Traditionally, seaweed has been used as a food for postpartum cooking. For mothers, seaweed increases lactation, constricts postpartum uterus, and heals wounds to help postpartum recovery. Basically, seaweed has been established as an essential postpartum care food with functions such as clearing blood, restoring Gi, and promoting metabolism to improve rough skin and improve constipation.
또한 미역 속에는 사람에게 필요한 영양과 기능들이 있기 때문에 일반인에게도 기능식품 및 기호식품으로 애용되어 오고 있다. In addition, the seaweed has been used as a functional food and a favorite food for the general public because there are nutrition and functions necessary for humans.
중국 당나라 유서(類書) 초학기(初學記)에, 고래가 새끼를 낳고 입은 상처를 치유하기 위해 미역을 뜯어 먹는 것을 본 고려인들이 산모에게 미역을 먹게 했다는 기록이 남아 있는 것으로 보아, 적어도 1300년 전부터 우리 민족은 미역을 산모를 위한 필수식품으로 애용해 왔음을 알 수 있다.In the early semester of the Chinese Tang Dynasty, there is a record that the Koreans, who saw whales pluck seaweed in order to heal their wounds, gave birth to them to eat seaweed, at least 1300 years ago. We can see that Korean people have used seaweed as an essential food for mothers.
동의보감에는 해채(海菜)는 열이 나고 답답한 것을 없애고 기가 뭉친 것을 치유하며 소변을 잘 나오게 한다고 기재되어 있다. Haebogam (海菜) is said to remove fever and stuffiness, heal the clumps and urinate well.
일본에서도 미역을 산후선약(産後仙藥)이라고 하여 산후조리식품으로 애용하고 있다.In Japan, seaweed is known as a postpartum medicine and is used as a postpartum cooked food.
미역 속에는 우리 몸들이 필요한 모든 미네랄을 함유하고 있으며 그 함유비율은 식품 중에서 우리 몸에 들어 있는 미네랄과 가장 유사하다(표 1).In seaweed, our bodies contain all the minerals our bodies need and their proportions are most similar to those in our bodies (Table 1).
<표 1> RDA(미국 미네랄 1일 권장섭취량)와 미역에 포함된 미네랄의 비교표<Table 1> Comparison of minerals contained in RDA (U.S. mineral daily recommended intake) and seaweed
미네랄 중 칼슘은 우리 몸에서 제일 많은 양의 미네랄이며 생명 활동에 아주 중요한 역할을 하는 미네랄이다. 체중의 2%나 되는 칼슘 중에서 약 99%는 뼈와 이 등에 있고 나머지 1%는 혈액, 세포의 벽, 침, 정액 등에 이온 상태로 존재한다. Among the minerals, calcium is the most abundant mineral in our body and is a mineral that plays a very important role in life activities. Of the 2% of the body's calcium, about 99% is in bones and teeth, and the remaining 1% is in ions in the blood, cell walls, saliva, and semen.
이온 상태로 혈액 속에 존재하는 소량의 칼슘은 심장박동, 근육수축, 호르몬 체계, 뇌, 눈, 귀 등의 모든 기능조절은 물론 혈액 응고, 효소활성 등 복잡한 메커니즘에 중요한 역할을 한다. Small amounts of calcium in the ionic state play an important role in complex mechanisms such as blood coagulation and enzyme activity, as well as regulating all functions of the heartbeat, muscle contraction, hormonal system, brain, eyes and ears.
칼슘이 부족하면 뇌의 부갑상선에서 칼슘의 농도를 조절하는 호르몬을 분비하고 이 조절장치는 뼈나 이 등에서 칼슘을 빼내어가 소모한다. 특히 임산부에게는 더 많은 영향을 미치는 미량 영양소이다. If you lack calcium, your brain's parathyroid glands secrete hormones that regulate calcium levels, and these regulators drain calcium from bones and teeth. In particular, it is a micronutrient that has more effect on pregnant women.
요오드는 체내에서 약 25mg 밖에 존재하지 않지만 갑상선 호르몬에 작용하여 신진대사를 활발하게 하는 대단히 중요한 미네랄이다. 요오드가 부족하면 신진대사가 잘 이루어지지 않아 몸 전체에 노화가 빠르게 진행된다. Iodine is only about 25mg in the body, but it is a very important mineral that acts on thyroid hormones to boost metabolism. If you lack iodine, your metabolism will not go well and your aging will progress quickly.
충분한 요오드의 공급은 대사기능, 지능발달에 중요한 일을 한다. 또 탄력 있는 피부, 윤기나는 머리칼을 만들며 아이들의 성장과 두뇌 발달에 영향을 주어 미역이 IQ식품, 성장식품, 미용식품 등으로 불리는 이유가 바로 요오드에 있음을 알 수 있다. 요오드는 육지에서 자란 식물에서는 전혀 섭취할 수가 없으며 오직 미역 등 해조류에서만 섭취할 수가 있을 뿐이다. Sufficient iodine supply is important for metabolic and intelligence development. In addition, it creates elastic skin, shiny hair and affects children's growth and brain development, which shows why seaweed is called IQ foods, growth foods and beauty foods. Iodine is not available at all on land-grown plants, but only in seaweed, such as seaweed.
미역에는 이외에도 셀렌 등 인체가 필요로 하는 모든 미네랄을 거의 갖고 있다. 미네랄뿐만 아니라 미역에는 오메가3 고도불포화 지방산 DHA, DPA 등과 글루타민산, 시스틴, 트립토판, 리신 등 아미노산도 함유하고 있다. In addition to seaweed, it has almost all the minerals needed by the human body, such as selenium. In addition to minerals, wakame contains amino acids such as omega-3 polyunsaturated fatty acids DHA and DPA and glutamic acid, cystine, tryptophan and lysine.
미역 속에 있는 만니톨은 가장 좋은 이뇨제이고 산후부기를 예방하고 치유하며 자궁수축에 효과가 있는 것으로 알려져 있다.Mannitol in seaweed is the best diuretic and is known to be effective in preventing and healing postpartum uterine contractions.
미역 속에 30%나 들어있는 알긴산은 중금속 등 유해물질의 해독작용(Detoxification), 콜레스테롤 감소, 고혈압/동맥경화 예방과 개선, 변비, 정장효과, 다이어트 효과 등 이미 수천 편의 연구논문들로 발표되고 있다.Alginic acid, contained 30% in seaweed, has already been published in thousands of research papers, including detoxification of harmful substances such as heavy metals, cholesterol reduction, hypertension and atherosclerosis prevention, constipation, formal effects, and dietary effects.
후코이단은 황산화 후코스(U-focus)를 주성분으로 하는 황산화다당류(Sulfated Polysaccharides)로서 갈락토오스, 만노스, 자일로스 등의 당과 황산(sulfate), 우론산(uronic acid) 등이 결합한 구조를 갖고 있다Fucoidan is a sulfated polysaccharide whose main component is sulfated fucose (U-focus), and has a structure in which sugars such as galactose, mannose, and xylose, sulfate, and uronic acid are combined. have
후코이단은 갈조 해조류가 갖고 있는 생리활성물질의 핵심물질로 알려져 있으며, 연구발표된 기능들을 보면 특히 아포토시스(apoptosis)작용, 혈액정화기능, 항체면역기능, 피부재생기능, 항바이러스, 항균, 위장개선, 변비, 항산화작용 등과 생리작용의 생체밸런스가 깨져서 오는 모든 생활습관병 등의 예방과 개선에 효과를 발휘한다고 발표되고 있다. Fucoidan is known as a key substance of bioactive substances in brown algae, and the research and published functions show apoptosis, blood purification, antibody immunity, skin regeneration, antiviral, antibacterial, gastrointestinal improvement, It is reported to be effective in preventing and improving all lifestyle diseases caused by constipation, antioxidant activity, and biological balance of physiological effects.
이 미역 속에 함유되어 있는 알긴산과 후코이단은 미역의 미끌미끌한 점질물에 포함되어 있는 기능성 물질로 현대인의 생활습관병에 좋은 효능을 보이고 있다(표 2)Alginic acid and fucoidan contained in this seaweed are functional substances contained in the slimy slime of seaweed and show good efficacy in modern lifestyle diseases (Table 2).
<표 2> 알긴산과 후코이단의 기능성Table 2 Functionalities of Alginic Acid and Fucoidan
이 중 알긴산은 미역에 들어 있는 양이 많아 미역을 먹는 것만으로 그 기능성을 충분히 작용할 수 있으나 생리활성물질의 핵심물질인 후코이단은 거의 폐기처분되는 미역포자엽(미역귀)에 집중되어 있고, 일반적으로 상용하는 미역엽체에는 너무 미량이 들어있어 먹는 미역만으로는 후코이단이 갖고 있는 기능성을 생체에서 기대하기 어렵다(표 3). Among them, alginic acid has a large amount of seaweed, so it can be fully functional by simply eating seaweed, but fucoidan, a key substance of bioactive substance, is concentrated in almost discarded seaweed spores (seaweed ear) and is commonly used. Seaweed leaves contain too small amounts, so it is difficult to expect the functionalities of fucoidan from living organisms.
<표 3> 미역엽체과 미역포자엽의 후코이단의 함유량(생물기준)<Table 3> Contents of Fucoidan of Wakame Leaf and Wakame Spores (Bio-based)
본 발명은 우리가 먹는 미역 속에는 후코이단이 생체기준 0.15% 정도의 미량 함유되어 있어 일반적인 방법으로 미역을 섭취해서는 생리활성의 핵심물질인 후코이단이 갖고 있는 기능들을 충분히 활용할 수 없다는 문제점을 해결하기 위한 것이다.The present invention is to solve the problem that the fucoidan in the seaweed we eat contains a trace amount of about 0.15% of the biological standard, and ingesting the seaweed in a general manner does not fully utilize the functions of the fucoidan, which is a key substance of physiological activity.
이를 위해, 본 발명은 후코이단이 다량 들어 있는 미역포자엽 또는 기타 갈조해조류에서 후코이단을 추출하여 미역추출물에 첨가함으로써 미역이 본래 갖고 있는 약리작용을 증대시켜 임산부와 태아에게나 수유하는 아기에게 유익한 임산부용 식품 및 건강기능식품을 제공하는 것을 목적으로 한다. To this end, the present invention is to increase the pharmacological action of seaweed by extracting the fucoidan from seaweed poscissium or other brown algae algae containing a large amount of fucoidan to the seaweed extract to increase the pharmacological action of the seaweed and the benefit for pregnant women and babies lactating It aims to provide health functional food.
상기와 같은 목적을 이루기 위해서, 본 발명의 일 양상에 따른 후코이단을 보강한 미역추출물은 갈조해조류, 바람직하게는 미역포자엽에서 추출한 후코이단을 미역 추출물에 첨가한 것을 특징으로 한다. In order to achieve the above object, the seaweed extract reinforced with fucoidan according to an aspect of the present invention is characterized in that it is added to the seaweed extract fucoidan extracted from brown algae, preferably seaweed spores.
또한, 본 발명의 다른 양상에 따른 후코이단을 보강한 미역추출물의 제조방법은; 염분을 제거한 건(乾) 미역 또는 생(生) 미역을 거칠게 파쇄한 후 파쇄한 원료를 필터용 자루에 적당량씩 담아 넣고, 이를 압력추출기에 넣고, 물을 건미역 1kg당 7ℓ~10ℓ, 생미역 1kg당 5ℓ~ 10ℓ 비율로 부은 후, 80℃~120℃ 온도에서 30분~240분 동안 추출기 내의 물을 순환시키면서 끓인 후, 고액 분리하여 추출물을 수득하는 미역추출물의 제조단계; 마른 포자엽을 분쇄한 후 분쇄한 포자엽을 필터 용 자루에 적당량씩 담아 넣고, 이를 압력추출기에 넣고, 물을 건(乾) 포자엽 1kg당 물 7~15ℓ의 비율로 붓고, PH를 2~4로 조정한 후, 80℃~120℃ 온도에서 90분~240분 동안 추출기 내의 물을 순환시키면서 끓인 후, 고액 분리하여 추출물을 수득하는 후코이단추출물의 제조단계; 상기 미역추출물과 상기 후코이단추출물을 일정 비율 혼합하는 혼합단계;를 포함하는 것을 특징으로 한다.In addition, the manufacturing method of seaweed extract reinforced with fucoidan according to another aspect of the present invention; After the salt is removed, the dried seaweed or fresh seaweed is roughly crushed, and the crushed raw material is placed in a filter bag in an appropriate amount, and it is put in a pressure extractor, and the water is put into 7ℓ ~ 10ℓ per 1kg dried seaweed, and 1kg of brown seaweed. After pouring at a rate of 5l ~ 10l, boiled while circulating water in the extractor for 30 minutes to 240 minutes at a temperature of 80 ℃ ~ 120 ℃, after the solid-liquid separation to prepare an extract of seaweed extract; After crushing the dried spores, put the crushed spores in an appropriate amount in a filter bag, put them in a pressure extractor, pour water at a ratio of 7-15 l of water per 1 kg of dried spores, and adjust the pH to 2-4. After the boil while circulating water in the extractor for 90 minutes to 240 minutes at a temperature of 80 ℃ ~ 120 ℃, the solid-liquid separation to obtain an extract to obtain the extract; And a mixing step of mixing the seaweed extract and the fucoidan extract in a predetermined ratio.
본 발명의 후코이단을 보강한 미역추출물은, 산모가 미역국을 통해 얻었던 전통적인 미역 유래의 유효성분이 모두 포함되어 있을 뿐만 아니라 생리활성물질인 후코이단이 강화되어 있으므로 미역국보다 우수한 약리 효과를 기대할 수 있다. Seaweed extract reinforcing fucoidan of the present invention, as well as all of the traditional seaweed-derived active ingredients mothers obtained through seaweed soup, as well as the bioactive substance fucoidan is enhanced because it can be expected to have a better pharmacological effect than seaweed soup.
더구나 본 발명의 후코이단을 보강한 미역추출물은, 미역국과는 달리 휴대가 가능하고 복용이 간편하며 장기간 계속적인 복용에도 질리지 않으므로 임산부의 꾸준한 섭취를 가능하게 한다. 이는 미역 유래의 유효성분을 태아에게 전이하고 질 높은 모유를 아기에게 수유할 수 있게 되는 결과를 가져와 결국 튼튼한 아기를 기르는 데도 기여할 것이다. Moreover, the seaweed extract reinforcing fucoidan of the present invention, unlike the seaweed soup, is portable and easy to take, and does not get tired of continuous taking for a long time, so that it is possible for a pregnant woman's steady intake. This will result in the transfer of active ingredients derived from seaweed to the fetus and the feeding of high quality breast milk to the baby, which will eventually contribute to raising a strong baby.
또한, 본 발명의 후코이단을 보강한 미역추출물은, 날로 산성화되어 가는 현대인의 체질을 개선하고 변비와 비만, 고혈압 등 성인병을 방지하는 데에도 효과가 뛰어나며 화학처리를 하지 않은 순수 자연식품으로서 인체에 부작용이 없으므로 전국민의 건강 및 체력증진을 위한 자연 건강기능식품으로 널리 이용될 수 있다.In addition, the seaweed extract reinforcing fucoidan of the present invention is effective in preventing the adult diseases such as constipation, obesity, high blood pressure and improve the constitution of modern man who is acidified day by day, as a pure natural food without chemical treatment side effects to the human body Since it is not present, it can be widely used as a natural dietary supplement for health and fitness of the whole nation.
본 발명에 따른 후코이단을 보강한 미역추출물의 제조방법을 각 공정에 따라 구체적으로 살펴보면 다음과 같다.Looking at the manufacturing method of the seaweed extract reinforced with fucoidan according to the present invention according to each process as follows.
<미역추출물의 제조><Production of Seaweed Extracts>
염분이 제거된 마른 미역을 분쇄한 것 또는 염장미역을 세척, 탈염한 후 절단한 것을 재료로 준비하여 사용한다. 세척한 미역은 미역 kg당 물 5~10ℓ, 마른미역은 1kg당 물 7~10ℓ의 비율로 압력 추출기에 넣고 80~120℃ 온도에서 30분~ 240분, 바람직하게는 160분 동안 추출기 내의 물을 순환시키면서 끓인 후 이를 필터 또는 압착탈수기를 이용하여 고액 분리하여 추출물을 얻는다.Crushed and dried salted seaweed or prepared by washing and desalting salted seaweed. The washed seaweed is placed in a pressure extractor at a rate of 5-10 l of water per kg of wakame seaweed and 7-10 l of water per kg of seaweed, and the water in the extractor for 30-240 minutes at a temperature of 80-120 ° C., preferably 160 minutes. After boiling while circulating, the extract is obtained by solid-liquid separation using a filter or a press dehydrator.
선택적으로 상기 미역 추출물에서 색소와 해조취 등을 제거할 수 있다. 예컨대, 카본여과기를 이용하여 탈취하고, 한외여과기로 색소와 부유물을 제거하여 맑은 추출물을 얻을 수 있다. Optionally, the seaweed extract may remove pigments and seaweed odors. For example, it is possible to obtain a clear extract by deodorizing using a carbon filter and removing pigments and suspended solids with an ultrafilter.
이렇게 얻어진 추출물을 3~7brix로 농축한다.The extract thus obtained is concentrated to 3 ~ 7brix.
<후코이단의 제조><Production of Fucoidan>
마른 포자엽을 분쇄한 후 분쇄한 포자엽을 40~100g/㎡의 필터용 자루에 3~5kg씩 넣는다. 건 포자엽 1kg당 물 7~15ℓ의 비율로 하여 압력 추출기에 넣고 염산, 또는 유기산을 PH2~4으로 조정한 후 물을 회전시키면서 짧게는 90분 길게는 240분 동안 80~120℃로 끓인다.After crushing the dry spores and put the crushed spores in the bag for 40 ~ 100g / ㎡ 3 ~ 5kg each. Put the pressure extractor in the ratio of 7-15ℓ of water per 1kg of dried coriander and adjust hydrochloric acid or organic acid to PH2 ~ 4 and boil it at 80 ~ 120 ℃ for 240 minutes while rotating water for 90 minutes.
다 끓인 포자엽은 압력추출기의 아래 콕크를 열면 압력추출기의 내부압력과 대기압간의 압력차에 의해 추출기 내의 해조류 추출액은 필터용 자루로부터 자동 분리된다.When the boiled spores are opened under the pressure extractor, the algae extract in the extractor is automatically separated from the filter bag by the pressure difference between the internal pressure of the pressure extractor and the atmospheric pressure.
이렇게 수득한 추출물은 공지의 염화칼슘을 이용하여 알긴산을 제거하고 후코이단 만을 취득한다. 취득한 후코이단은 한외여과기를 이용하여 투석하고 정제한 후코이단을 수득한다. 이때 후코이단의 순도는 80~85% 내외이다.The extract thus obtained is obtained by removing alginic acid using known calcium chloride to obtain only fucoidan. The obtained fucoidan is obtained by dialysis and purification using an ultrafilter. At this time, the purity of fucoidan is around 80 ~ 85%.
이렇게 추출된 후코이단 추출물을 10brix로 농축한다.The fucoidan extract thus extracted is concentrated to 10brix.
<후코이단을 보강한 미역추출물의 제조><Production of Seaweed Extracts Reinforced Fucoidan>
상기 미역추출물과 상기 후코이단추출물을 혼합하여 후코이단을 보강한 미역추출물을 제조한다. 미역추출물과 후코이단의 혼합비는 후코이단의 하루 섭취 권장량에 근거하는 것이 바람직하다. 참고로, 출산 후 회복을 위하여 권장되는 후코이단의 하루 섭취량은 약 1g에서 2g 정도이다. The seaweed extract and the fucoidan extract are mixed to prepare a seaweed extract reinforced with fucoidan. The mixing ratio of seaweed extract and fucoidan is preferably based on the recommended daily intake of fucoidan. For reference, the daily intake of fucoidan recommended for recovery after childbirth is about 1g to 2g.
이하에서 실시예를 통하여 본 발명의 구성 및 작용효과를 보다 구체적으로 설명한다. 그러나 하기의 실시예는 본 발명을 구체적으로 예시하기 위한 것일 뿐, 본 발명의 권리범위를 제한하는 것이 아님은 당업자에게 있어서 명백한 사실이다. 즉, 본 발명의 단순한 변형 내지 변경은 당업자에 의하여 용이하게 실시될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다.Hereinafter, the configuration and operation of the present invention will be described in more detail with reference to the following examples. However, the following examples are only intended to specifically illustrate the present invention, it is obvious to those skilled in the art that the scope of the present invention is not limited. That is, simple modifications or changes of the present invention can be easily carried out by those skilled in the art, and all such modifications or changes can be seen to be included in the scope of the present invention.
실시예Example
1. 미역추출물의 제조1. Preparation of Seaweed Extract
염장미역 1kg를 세척 완전 탈염하고 사방 35 x 50cm의 부직포자루 2개에 각 0.5kg씩 나누어 담은 후 30ℓ 짜리 압력추출기에 5ℓ의 물을 부었다. 상기 추출기의 온도를 120℃의 온도에 맞추고 추출기 안의 물을 상하 좌우로 회전하도록 하였다. 1kg of salted seaweed was washed and desalted, and 0.5kg each of two nonwoven fabric bags of 35 x 50cm was poured in each, and 5ℓ of water was poured into a 30ℓ pressure extractor. The temperature of the extractor was adjusted to a temperature of 120 ° C. and the water in the extractor was rotated up, down, left, and right.
추출기 내부의 온도가 상승하여 120℃가 되었을 때 추출기 내의 압력은 1.5bar(1.5kgt)였다. 120℃의 온도, 1.5bar의 압력을 유지하면서 60분이 지난 뒤 불을 끄고 20여 분 뒤 추출기의 아래 콕크를 열고 추출기 안의 추출액이 압력차에 의해 빠져나오도록 하여 고액분리하였다. 분리한 추출액은 4 ℓ였다.The pressure in the extractor was 1.5 bar (1.5 kgt) when the temperature inside the extractor rose to 120 ° C. After 60 minutes, the fire was turned off after maintaining the temperature of 120 ° C. and the pressure of 1.5 bar. After 20 minutes, the bottom cock of the extractor was opened, and the extract liquid in the extractor was separated by the pressure difference, thereby separating the liquid. The extracted extract was 4 L.
추출한 여액을 야자활성탄과 한외여과 MW50만으로 여과하여 부유물과 색소를 제거, 탈취하고 2.5ℓ의 미역추출물을 얻고 이를 5brix로 농축하여 990ml의 미역 추출물을 만들었다. The extracted filtrate was filtered with palm activated carbon and ultrafiltration MW50 only to remove and deodorize suspended solids and pigments, to obtain 2.5 L of seaweed extract, which was concentrated to 5brix to make 990ml of seaweed extract.
2. 후코이단의 추출2. Extraction of Fucoidan
건미역포자엽 1kg를 거칠게 분쇄하여 사방 35 x 50cm의 부직포 자루에 넣은 후 상기 자루를 30ℓ의 압력추출기에 넣고 물 7ℓ를 채우고 PH4로 맞추었다.Roughly crushed 1kg dry seaweed spores coarse into a nonwoven bag of 35 x 50cm in all directions, the bag was placed in a 30l pressure extractor filled with 7l of water and adjusted to PH4.
상기 압력추출기의 온도를 120℃로 조정하고 상기 미역추출물과 동일한 방법으로 조작하여 미역포자엽 추출물을 3.8ℓ의 추출물을 회수하였다. The temperature of the pressure extractor was adjusted to 120 ° C. and operated in the same manner as the wakame extract to recover 3.8 L of wakame spores extract.
상기 추출물에 1M의 염화칼슘액을 만들고 30℃의 온도에서 2시간을 교반하고1M calcium chloride solution was prepared in the extract and stirred at a temperature of 30 ° C. for 2 hours.
침전한 알긴산을 제거하고 조후코이단 여액 2ℓ를 수득하였다.Precipitated alginic acid was removed to obtain 2 L of crude fucoidan filtrate.
상기 조후코이단을 야자활성탄과 50만 MW의 UF (Fall사 제품)로 탈취하고 색소를 제거한 후 투석 농축하여 10brix 250ml의 정제한 후코이단 용액을 수득하였다.The crude fucoidan was deodorized with palm activated carbon and 500,000 MW of UF (Fall Co., Ltd.), the pigment was removed, and concentrated by dialysis to obtain a purified fucoidan solution of 10brix 250ml.
3. 후코이단을 보강한 미역추출물의 제조3. Preparation of Seaweed Extracts Reinforced Fucoidan
일반적으로 염장미역 30g는 미역국 1회용 분량이다. 이를 추출물로 환산하면 30㎖이다. 이 추출물 속에 미역포자엽 유래의 후코이단 10ml(1g)를 첨가하여 1회용으로 할 수 있다. 이 분량을 기준으로 하여 미역이 함유하고 있는 미네랄과 알긴산, 그리고 후코이단을 보완하여 생리활성 기능을 최대화한 임산모의 몸조리식품 및 건강기능식품을 제조하였다.Generally, 30g of salted seaweed is a one-time serving of seaweed soup. It is 30 ml in terms of extract. In this extract, 10 ml (1 g) of fucoidan derived from wakame cotyledons can be added for single use. On the basis of this amount, supplemented minerals, alginic acid, and fucoidan in seaweed were prepared to prepare pregnant women's body foods and health functional foods.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080024574A KR20090099374A (en) | 2008-03-17 | 2008-03-17 | Fucoidan-enriched extract of brown-seaweed and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080024574A KR20090099374A (en) | 2008-03-17 | 2008-03-17 | Fucoidan-enriched extract of brown-seaweed and its manufacturing method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090099374A true KR20090099374A (en) | 2009-09-22 |
Family
ID=41357990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080024574A KR20090099374A (en) | 2008-03-17 | 2008-03-17 | Fucoidan-enriched extract of brown-seaweed and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20090099374A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3153173A1 (en) * | 2010-06-28 | 2017-04-12 | Stemtech International, Inc. | Methods and compositions for enhancing stem cell mobilization |
-
2008
- 2008-03-17 KR KR1020080024574A patent/KR20090099374A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3153173A1 (en) * | 2010-06-28 | 2017-04-12 | Stemtech International, Inc. | Methods and compositions for enhancing stem cell mobilization |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102077936B (en) | Special sea dietary food for diabetics | |
EA027651B1 (en) | Biologically active food additive for normalizing the function of the thyroid gland | |
CN102422938B (en) | Tea for preventing and treating elderly constipation and preparation method thereof | |
CN103610076A (en) | Preparation method for sea cucumber capsule | |
CN102018158A (en) | Aloe jam | |
CN104273579A (en) | Healthcare enteromorpha prolifera capsules | |
KR101160196B1 (en) | Functional food and method of preparing thereof | |
KR20090099374A (en) | Fucoidan-enriched extract of brown-seaweed and its manufacturing method | |
CN102077935B (en) | Marine special dietary food special for vision recession patient | |
CN108740631A (en) | Compound fruit and vegetable juice weight reducing beverage for the high calcium low sugar that relaxes bowel and preparation method thereof | |
KR101294454B1 (en) | A Functional Salt Containing Salicornia herbacea Extracts and its Manufacturing Method | |
KR101236764B1 (en) | Herbal health food And manufacturing method | |
CN103610069A (en) | Blood-sugar-reducing sea cucumber oral liquid | |
CN103610116A (en) | Preparation method for sea cucumber nutritional capsule | |
CN107874061A (en) | A kind of oyster solid beverage preparation method for nourishing U.S. face | |
CN102077941A (en) | Special dietary seafood special for climacteric women | |
KR20090029470A (en) | Sweety flavour opuntia madical tea beverage | |
KR20090025106A (en) | Sweet flavorous the collagen turkey tail tea and water | |
CN103610070A (en) | Blood-fat-reducing sea cucumber oral liquid and application method thereof | |
CN103610117A (en) | Sea cucumber nutritional oral liquid | |
CN104585769A (en) | Allicin-containing compound product and preparation method for compound product | |
CN103610033A (en) | Immunity-enhancing sea cucumber oral liquid | |
CN103610073A (en) | Sea cucumber oral liquid and application method thereof | |
CN103933420A (en) | Natural green element traditional Chinese medicine multi-gourd powder for reducing and controlling blood sugar | |
CN103610071A (en) | Preparation method for blood-pressure-reducing sea cucumber oral liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |